{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:44:36Z","timestamp":1785905076944,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007867","name":"Universit\u00e9 Laval","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jogc.2026.103373","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:11:37Z","timestamp":1777306297000},"page":"103373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio for the Prediction of Preeclampsia in Asymptomatic Women"],"prefix":"10.1016","volume":"48","author":[{"given":"Brielle","family":"Demuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Guerby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Pellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Blouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"L\u00e9vesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Boutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Gigu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Forest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Ghesqui\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6936-4369","authenticated-orcid":false,"given":"Emmanuel","family":"Bujold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2026.103373_bib1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jogc.2026.103373_bib2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2026.103373_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/1471-0528.17560","article-title":"Adverse pregnancy outcomes in women at increased risk of preterm pre-eclampsia on first-trimester combined screening","volume":"131","author":"Minopoli","year":"2024","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2026.103373_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.earlhumdev.2016.09.007","article-title":"Preeclampsia; short- and long-term consequences for mother and neonate","volume":"102","author":"Bokslag","year":"2016","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.jogc.2026.103373_bib5","first-page":"467","article-title":"Pre-eclampsia: pathophysiology, diagnosis, and management","volume":"7","author":"Uzan","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jogc.2026.103373_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ogc.2010.02.013","article-title":"Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia","volume":"37","author":"Silasi","year":"2010","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.jogc.2026.103373_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"Ogge","year":"2011","journal-title":"J Perinat Med"},{"key":"10.1016\/j.jogc.2026.103373_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2025.102963","article-title":"Prospective study evaluating the association between sFlt-1\/PlGF ratio and adverse outcomes in preterm preeclampsia","volume":"47","author":"Ghesqui\u00e8re","year":"2025","journal-title":"J Obstet Gynaecol Can"},{"issue":"Suppl A","key":"10.1016\/j.jogc.2026.103373_bib9","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","volume":"30","author":"Roberts","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.jogc.2026.103373_bib10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2026.103373_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jogc.2026.103373_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated before the clinical diagnosis of pre-eclampsia","volume":"17","author":"Chaiworapongsa","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2026.103373_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050500202493","article-title":"Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin","volume":"18","author":"Bujold","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2026.103373_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2026.103373_bib15","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jogc.2017.07.014","article-title":"First and second trimester serum sFlt-1\/PlGF ratio and subsequent preeclampsia: a systematic review","volume":"40","author":"Yusuf","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2026.103373_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2026.103373_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2025.102925","article-title":"Predictive performance of sFlt-1, PlGF and the sFlt-1\/PlGF ratio for preeclampsia: a systematic review and meta-analysis","volume":"54","author":"Zhang","year":"2025","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.jogc.2026.103373_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2024.102759","article-title":"Proposed utilization of PlGF-based diagnostic testing for suspected preeclampsia in Qu\u00e9bec: insights from an expert panel discussion","volume":"47","author":"Malham\u00e9","year":"2025","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2026.103373_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2025.103076","article-title":"Placental growth factor diagnostic testing: an opportunity to transform pregnancy care for patients with suspected preeclampsia in Canada","volume":"47","author":"McLaughlin","year":"2025","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2026.103373_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2025.103120","article-title":"Implementation of placental growth factor in a tertiary Western Canadian centre: association with ultrasound findings and perinatal outcomes","volume":"47","author":"Figueiro-Filho","year":"2025","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2026.103373_bib21","article-title":"Placental growth factor and fetal macrosomia: A retrospective cohort study in a Western Canadian tertiary centre","volume":"48","author":"Figueiro-Filho","year":"2026","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2026.103373_bib22","article-title":"First-trimester PlGF and PAPP-A and the risk of placenta-mediated complications: PREDICTION prospective study","volume":"47","author":"C\u00f4t\u00e9","year":"2025","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2026.103373_bib23","doi-asserted-by":"crossref","first-page":"S426","DOI":"10.1016\/j.jogc.2016.09.052","article-title":"Diagnostic, \u00e9valuation et prise en charge des troubles hypertensifs de la grossesse: r\u00e9sum\u00e9 directif","volume":"38","author":"Magee","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2026.103373_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.021376","article-title":"Decision threshold for Kryptor sFlt-1\/PlGF ratio in women with suspected preeclampsia: retrospective study in a routine clinical setting","volume":"10","author":"Andersen","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jogc.2026.103373_bib25","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1515\/cclm-2013-0955","article-title":"Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women","volume":"52","author":"Forest","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jogc.2026.103373_bib26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.116.08620","article-title":"Prediction of preeclampsia using the soluble fms-like tyrosine kinase 1 to placental growth factor ratio: a prospective cohort study of unselected nulliparous women","volume":"69","author":"Sovio","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jogc.2026.103373_bib27","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jogc.2020.03.024","article-title":"Placental growth factor and soluble, Fms-like tyrosine Kinase-1 in preeclampsia: a case-cohort (PEARL) study","volume":"42","author":"Fillion","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2026.103373_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12884-024-06627-4","article-title":"A dynamic prediction model for preeclampsia using the sFlt-1\/PLGF ratio combined with multiple factors","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jogc.2026.103373_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/uog.17399","article-title":"Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216326001751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216326001751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:51:21Z","timestamp":1785901881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216326001751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1701216326001751"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2026.103373","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio for the Prediction of Preeclampsia in Asymptomatic Women","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2026.103373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier Inc. on behalf of The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada.","name":"copyright","label":"Copyright"}],"article-number":"103373"}}